Paul DiMeo: Extreme Cholesterol Makeover

Page: 1 2 3 4 (of 4)	Previous | Next

Rebuilding Heart Health Together

When Paul found out that 60 percent of U.S. adults being treated with cholesterol-lowering statins did not know their target cholesterol goal—and even fewer people knew what atherosclerosis is—he wanted to help educate others. He joined forces with AstraZeneca, the maker of Crestor, on a campaign called Us Against Athero (athero.com). The campaign’s goal is to raise awareness about atherosclerosis and encourage people to improve the health of their arteries.

“A cholesterol-lowering program is a lot like a home makeover project, “ Paul says. “You have to determine a specific goal, identify the necessary steps to reach that goal, and work according to plan, checking in on your progress along the way.”